{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:16:11Z","timestamp":1792721771582,"version":"4.5.0"},"reference-count":259,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.arr.2024.102276","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:35:58Z","timestamp":1710606958000},"page":"102276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology"],"prefix":"10.1016","volume":"96","author":[{"given":"Sania","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Aiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemi Farhat","family":"Basir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-7970","authenticated-orcid":false,"suffix":"Professor","given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102276_bib1","unstructured":"Agarwal, S.; Gilbert, R. Progressive supranuclear palsy. 2018."},{"key":"10.1016\/j.arr.2024.102276_bib2","first-page":"153","article-title":"Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation","volume":"23","author":"Ahanger","year":"2024","journal-title":"CNS Neurol. Disord. -Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord. )"},{"key":"10.1016\/j.arr.2024.102276_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/srep26759","article-title":"Vitamin k3 inhibits protein aggregation: implication in the treatment of amyloid diseases","volume":"6","author":"Alam","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102276_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116888","article-title":"Probing the interaction of memantine, an important Alzheimer's drug, with human serum albumin: In silico and in vitro approach","volume":"340","author":"Alhumaydhi","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.arr.2024.102276_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1389450122666210623115505","article-title":"Disease: A Current Perspectives on Parkinson\u2019s Disease and Key Bioactive Natural Compounds as Future Potential Drug Candidates","volume":"23","author":"Ali","year":"2022","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.arr.2024.102276_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02866241","article-title":"\u00dcber eigenartige Krankheitsf\u00e4lle des sp\u00e4teren Alters","volume":"4","author":"Alzheimer","year":"1911","journal-title":"Z. F. \u00fcR. die Gesamt Neurol. und Psychiatr."},{"key":"10.1016\/j.arr.2024.102276_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib8","first-page":"18","article-title":"Prion Diseases in Animals: Poster Abstracts","volume":"1","author":"An","year":"2013","journal-title":"Prion."},{"key":"10.1016\/j.arr.2024.102276_bib9","doi-asserted-by":"crossref","first-page":"11732","DOI":"10.3390\/ijms241411732","article-title":"Frontotemporal dementia, where do we stand? A narrative review","volume":"24","author":"Antonioni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2001-15269","article-title":"Tracing Woody Guthrie and Huntington's disease","author":"Ar\u00e9valo","year":"2001","journal-title":"Proc. Semin. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib11","first-page":"597","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology","volume":"79","author":"Armstrong","year":"2012"},{"key":"10.1016\/j.arr.2024.102276_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1007583214722","article-title":"Tau dephosphorylation at tau-1 site correlates with its association to cell membrane","volume":"25","author":"Arrasate","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102276_bib13","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity","volume":"16","author":"Atwal","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2024.102276_bib15","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/0006-2952(83)90388-X","article-title":"Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine","volume":"32","author":"Bagchi","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2024.102276_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ptj\/77.6.672","article-title":"Mechanisms of ataxia","volume":"77","author":"Bastian","year":"1997","journal-title":"Phys. Ther."},{"key":"10.1016\/j.arr.2024.102276_bib17","first-page":"1","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2024.102276_bib18","first-page":"5","article-title":"World Alzheimer Report 2012","author":"Batsch","year":"2015","journal-title":"Overcoming stigma Dement. Alzheimer\u2019S. Dis. Int. (ADI)"},{"key":"10.1016\/j.arr.2024.102276_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34759-z","article-title":"Aggregated SOD1 causes selective death of cultured human motor neurons","volume":"8","author":"Benkler","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102276_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.biochem.77.061306.131357","article-title":"Structure and energetics of the hydrogen-bonded backbone in protein folding","volume":"77","author":"Bolen","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102276_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(12)70320-4","article-title":"Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Boxer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib22","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1093\/hmg\/ddx260","article-title":"Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity","volume":"26","author":"Branco-Santos","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1083\/jcb.131.5.1327","article-title":"Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain","volume":"131","author":"Brandt","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.arr.2024.102276_bib24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-012-0928-2","article-title":"Non-motor symptoms of Parkinson\u2019s disease: the patient\u2019s perspective","volume":"120","author":"Breen","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2024.102276_bib25","unstructured":"Brizolla, N. Brand positioning in the pharmaceutical industry: content analysis applied to antiaging drugs. 2017."},{"key":"10.1016\/j.arr.2024.102276_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2024.102276_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2660(09)66001-6","article-title":"The molecular links between TDP-43 dysfunction and neurodegeneration","volume":"66","author":"Buratti","year":"2009","journal-title":"Adv. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnins.2017.00192","article-title":"Molecular chaperone accumulation in cancer and decrease in Alzheimer's disease: the potential roles of HSF1","volume":"11","author":"Calderwood","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/925101","article-title":"Amyotrophic lateral sclerosis: a focus on disease progression","volume":"2014","author":"Calvo","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.arr.2024.102276_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mds.22420","article-title":"Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies","volume":"24","author":"Cano","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102276_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2019.02.148","article-title":"Molecular chaperones biochemistry and role in neurodegenerative diseases","author":"Chaari","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102276_bib32","first-page":"968","article-title":"Frontotemporal dementia: Features, diagnosis and management","volume":"40","author":"Chan","year":"2011","journal-title":"Aust. J. Gen. Pract."},{"key":"10.1016\/j.arr.2024.102276_bib33","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1073\/pnas.1309613110","article-title":"Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy","volume":"110","author":"Chan","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12551-017-0353-8","article-title":"Recent progress on understanding the mechanisms of amyloid nucleation","volume":"10","author":"Chatani","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.arr.2024.102276_bib35","doi-asserted-by":"crossref","first-page":"S569","DOI":"10.3233\/JAD-2010-100357","article-title":"Role of mitochondrial amyloid-\u03b2 in Alzheimer's disease","volume":"20","author":"Chen","year":"2010","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102276_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/21678707.2019.1623022","article-title":"Progress and prospects for treating ataxia telangiectasia","volume":"7","author":"Chessa","year":"2019","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.arr.2024.102276_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S0004-282X2010000600002","article-title":"Amyotrophic lateral sclerosis: considerations on diagnostic criteria","volume":"68","author":"Chieia","year":"2010","journal-title":"Arq. De. neuro-Psiquiatr."},{"key":"10.1016\/j.arr.2024.102276_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study","volume":"82","author":"Chi\u00f2","year":"2011","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102276_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.22454","article-title":"Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease","volume":"70","author":"Chitravas","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108122","article-title":"Physiology and pharmacology of amyloid precursor protein","volume":"235","author":"Cho","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.arr.2024.102276_bib42","doi-asserted-by":"crossref","first-page":"13851","DOI":"10.1073\/pnas.1610716113","article-title":"Amyloid fibrils from the N-terminal prion protein fragment are infectious","volume":"113","author":"Choi","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib43","doi-asserted-by":"crossref","DOI":"10.2741\/2097","article-title":"The role of tau phosphorylation and cleavage in neuronal cell death","volume":"12","author":"Chun","year":"2007","journal-title":"Front Biosci."},{"key":"10.1016\/j.arr.2024.102276_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fncel.2016.00204","article-title":"A case for microtubule vulnerability in amyotrophic lateral sclerosis: altered dynamics during disease","volume":"10","author":"Clark","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1098\/rstb.2000.0764","article-title":"The molecular biology of prion propagation","volume":"356","author":"Clarke","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B\u00a0Biol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib46","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/jnnp.2004.048660","article-title":"Molecular neurology of prion disease","volume":"76","author":"Collinge","year":"2005","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/brain\/awz418","article-title":"Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion","volume":"143","author":"Cortese","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102276_bib49","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer's disease","volume":"19","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib50","doi-asserted-by":"crossref","first-page":"20075","DOI":"10.1073\/pnas.1320626110","article-title":"Unmasking the roles of N-and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation","volume":"110","author":"Crick","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/jsbi.2000.4270","article-title":"Abnormal tau-containing filaments in neurodegenerative diseases","volume":"130","author":"Crowther","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.arr.2024.102276_bib52","first-page":"25","article-title":"(Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis","volume":"43","author":"Cruz","year":"2018","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.arr.2024.102276_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2023.1168666","article-title":"Neurocognitive and cerebellar function in ADHD, autism and spinocerebellar ataxia","volume":"17","author":"Cundari","year":"2023","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib54","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1046\/j.1460-9568.2003.02662.x","article-title":"Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease","volume":"17","author":"Cunningham","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1242\/jcs.051672","article-title":"Prion-like disorders: blurring the divide between transmissibility and infectivity","volume":"123","author":"Cushman","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2024.102276_bib56","unstructured":"Daroff, R.B.; Fenichel, G.M.; Jankovic, J.; Mazziotta, J.C. Neurology in clinical practice; Elsevier Health Sciences: 2012."},{"key":"10.1016\/j.arr.2024.102276_bib57","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.compbiomed.2013.09.021","article-title":"Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of A\u03b2 peptide","volume":"43","author":"Dhanavade","year":"2013","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.arr.2024.102276_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib59","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102276_bib60","first-page":"1042","article-title":"The protein-folding problem","volume":"338","author":"Dill","year":"2012","journal-title":"50 years. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102276_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0306-4522(87)90276-4","article-title":"The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture","volume":"23","author":"Dotti","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102276_bib63","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1091\/mbc.3.10.1141","article-title":"Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau","volume":"3","author":"Drechsel","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.arr.2024.102276_bib64","unstructured":"Eig, J.. Luckiest Man: The Life and Death of Lou Gehrig; Simon and Schuster: 2005."},{"key":"10.1016\/j.arr.2024.102276_bib65","first-page":"469","article-title":"Classic charcot amyotrophic lateral sclerosis","volume":"Vol. 4","author":"Eisen","year":"2004"},{"key":"10.1016\/j.arr.2024.102276_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-biochem-061516-045104","article-title":"Structural studies of amyloid proteins at the molecular level","volume":"86","author":"Eisenberg","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102276_bib67","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4140\/TCP.n.2017.764","article-title":"Determination of anticholinergic medication use in patients prescribed medications for the treatment of dementia","volume":"32","author":"Ellard","year":"2017","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.arr.2024.102276_bib68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/BC.2006.064","article-title":"Protein aggregation in crowded environments","volume":"387","author":"Ellis","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia","volume":"57","author":"Englund","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib70","doi-asserted-by":"crossref","first-page":"a033118","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102276_bib71","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Van den Berg, L.H. Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2024.102276_bib72","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1261\/rna.045005.114","article-title":"Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets","volume":"20","author":"Farazi","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.arr.2024.102276_bib73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","article-title":"Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis","volume":"121","author":"Forsberg","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/NDT.S6430","article-title":"Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease","volume":"6","author":"Frank","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.arr.2024.102276_bib75","doi-asserted-by":"crossref","first-page":"26304","DOI":"10.1074\/jbc.M110.125039","article-title":"Interaction with polyglutamine aggregates reveals a Q\/N-rich domain in TDP-43","volume":"285","author":"Fuentealba","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib76","article-title":"Transmissible spongiform encephalopathies affecting humans","author":"GB","year":"2013","journal-title":"ISRN Infect. Dis. 2012"},{"key":"10.1016\/j.arr.2024.102276_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-73","article-title":"Characterization of tau oligomeric seeds in progressive supranuclear palsy","volume":"2","author":"Gerson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2024.102276_bib78","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Geschwind","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib79","doi-asserted-by":"crossref","unstructured":"Gholamzadeh, S.; Heshmati, B.; Mani, A.; Petramfar, P.; Baghery, Z. The prevalence of Alzheimer's disease; its risk and protective factors among the elderly population in Iran. 2017.","DOI":"10.5812\/semj.57576"},{"key":"10.1016\/j.arr.2024.102276_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3892\/br.2017.927","article-title":"Unraveling the genes implicated in Alzheimer's disease","volume":"7","author":"Giri","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.arr.2024.102276_bib81","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2024.102276_bib82","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1098\/rstb.1999.0466","article-title":"Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies","volume":"354","author":"Goedert","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib83","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","article-title":"Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau","volume":"85","author":"Goedert","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1750-3639.1991.tb00671.x","article-title":"Tau proteins and neurofibrillary degeneration","volume":"1","author":"Goedert","year":"1991","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2024.102276_bib85","unstructured":"Gordon, M.R. In poignant public letter, Reagan reveals that he has Alzheimer\u2019s. The New York Times 1994."},{"key":"10.1016\/j.arr.2024.102276_bib86","doi-asserted-by":"crossref","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","article-title":"Clinical spectrum of amyotrophic lateral sclerosis (ALS)","volume":"7","author":"Grad","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2024.102276_bib87","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","article-title":"N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice","volume":"85","author":"Gu","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102276_bib88","article-title":"Non-motor symptoms in Parkinson's disease: opening new avenues in treatment","volume":"2","author":"Gupta","year":"2021","journal-title":"Curr. Res. Behav. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00401-012-1030-4","article-title":"Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects","volume":"124","author":"Halliday","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/403808","article-title":"Pain in amyotrophic lateral sclerosis: a neglected aspect of disease","volume":"2011","author":"Handy","year":"2011","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.arr.2024.102276_bib91","series-title":"Nature reviews. Disease primers","first-page":"3","article-title":"Erratum: Amyotrophic lateral sclerosis (Nature reviews. Disease primers (2017) 3 (17071))","author":"Hardiman","year":"2017"},{"key":"10.1016\/j.arr.2024.102276_bib92","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"science"},{"key":"10.1016\/j.arr.2024.102276_bib93","unstructured":"Harmon, K. How has Stephen Hawking lived past 70 with ALS. Scientific American 2012."},{"key":"10.1016\/j.arr.2024.102276_bib94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-biochem-061516-044518","article-title":"Protein misfolding diseases","volume":"86","author":"Hartl","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102276_bib95","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102276_bib96","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.07-099671","article-title":"Molecular and cellular aspects of protein misfolding and disease","volume":"22","author":"Herczenik","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102276_bib97","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/JGP.0b013e31823033f3","article-title":"Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia","volume":"20","author":"Herrmann","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib98","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.23961","article-title":"Nonmotor versus motor symptoms: how much do they matter to health status in Parkinson's disease?","volume":"27","author":"Hinnell","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2024.102276_bib99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","article-title":"The discovery of Alzheimer's disease","volume":"5","author":"Hippius","year":"2003","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrneurol.2016.111","article-title":"Supportive and symptomatic management of amyotrophic lateral sclerosis","volume":"12","author":"Hobson","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1212\/01.WNL.0000078928.20107.52","article-title":"Survival in frontotemporal dementia","volume":"61","author":"Hodges","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102276_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-9158-1-21","article-title":"Current advances in the treatment of Alzheimer's disease: focused on considerations targeting A\u03b2 and tau","volume":"1","author":"Hong-Qi","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102276_bib103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbadis.2004.06.015","article-title":"Transcriptional and conformational changes of the tau molecule in Alzheimer's disease","volume":"1739","author":"Hyman","year":"2005","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102276_bib104","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.3390\/molecules20022510","article-title":"The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity","volume":"20","author":"Iannuzzi","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102276_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102276_bib106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.arr.2024.102276_bib107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.22246","article-title":"Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS\/TLS","volume":"69","author":"Ito","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib108","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102276_bib109","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/19336896.2017.1306164","article-title":"Hoshino, K.-i.; Kawabata, Y.; Mimuro, M.; Yoshida, M. Gastrostomy in patients with prion disease","volume":"11","author":"Iwasaki","year":"2017","journal-title":"Prion"},{"key":"10.1016\/j.arr.2024.102276_bib110","unstructured":"Jacoby, D.B.; Youngson, R.M. Encyclopedia of family health; Marshall Cavendish: 2004."},{"key":"10.1016\/j.arr.2024.102276_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/acs.jcim.7b00616","article-title":"Mol2vec: unsupervised machine learning approach with chemical intuition","volume":"58","author":"Jaeger","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.arr.2024.102276_bib112","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.58.suppl_1.S19","article-title":"Levodopa strengths and weaknesses","volume":"58","author":"Jankovic","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102276_bib113","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib114","first-page":"293","article-title":"Movement disorders: diagnosis and assessment","volume":"24","author":"Jankovic","year":"2004","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.arr.2024.102276_bib115","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jmb.2011.12.010","article-title":"Slow amyloid nucleation via \u03b1-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments","volume":"415","author":"Jayaraman","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2024.102276_bib116","doi-asserted-by":"crossref","first-page":"32066","DOI":"10.1074\/jbc.M805300200","article-title":"Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation","volume":"283","author":"Jeganathan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib117","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"investigators, C. Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","author":"Jen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102276_bib118","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2024.102276_bib119","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/nprot.2006.356","article-title":"Culturing hippocampal neurons","volume":"1","author":"Kaech","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.arr.2024.102276_bib120","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp-2011-301826","article-title":"Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?","volume":"83","author":"Kanouchi","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134564","volume":"715","author":"Katayama","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102276_bib122","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","article-title":"A full genome scan for late onset Alzheimer's disease","volume":"8","author":"Kehoe","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib123","unstructured":"Khan, I.; De Jesus, O. Frontotemporal lobe dementia. 2020."},{"key":"10.1016\/j.arr.2024.102276_bib124","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c00595","article-title":"Understanding the modulation of \u03b1-synuclein fibrillation by N-Acetyl aspartate: a brain metabolite","author":"Khan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102276_bib125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"lancet"},{"key":"10.1016\/j.arr.2024.102276_bib126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","article-title":"Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions","volume":"42","author":"Kim","year":"2018","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.arr.2024.102276_bib127","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(09)70305-9","article-title":"Sporadic ataxia with adult onset: classification and diagnostic criteria","volume":"9","author":"Klockgether","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib128","series-title":"In Neurological Disorders","first-page":"707","article-title":"Prion diseases","author":"Knight","year":"2003"},{"key":"10.1016\/j.arr.2024.102276_bib129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2024.102276_bib130","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/bi002156h","article-title":"Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the alzheimer's \u03b2 (25\u2212 35) Amyloid Fibril","volume":"40","author":"Konno","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102276_bib131","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.53.2.364","article-title":"A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson\u2019s disease","volume":"53","author":"Korczyn","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102276_bib132","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2004.10.011","article-title":"Phosphorylated tau and the neurodegenerative foldopathies","volume":"1739","author":"Kosik","year":"2005","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102276_bib133","first-page":"355","article-title":"Tauopathies","volume":"Volume 145","author":"Kovacs","year":"2018"},{"key":"10.1016\/j.arr.2024.102276_bib134","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0002-9440(10)62252-3","article-title":"Subcellular localization of disease-associated prion protein in the human brain","volume":"166","author":"Kov\u00e1cs","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2024.102276_bib135","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib136","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/138920307781369382","article-title":"Structure-based drug design: docking and scoring","volume":"8","author":"Kroemer","year":"2007","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib137","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/jnnp-2015-310697","article-title":"The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry","volume":"87","author":"Lanata","year":"2016","journal-title":"J. Neurol.\u00a0Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2024.102276_bib138","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease: fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.arr.2024.102276_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.arr.2024.102276_bib140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pharmtox-011613-135928","article-title":"Systems approach to neurodegenerative disease biomarker discovery","volume":"54","author":"Lausted","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2024.102276_bib141","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib142","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11910-008-0060-8","article-title":"The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer\u2019s disease","volume":"8","author":"Lee","year":"2008","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2024.102276_bib143","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1002\/mds.21684","article-title":"Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday","volume":"22","author":"Lees","year":"2007","journal-title":"Mov. Disord.\u00a0Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2024.102276_bib144","unstructured":"Licht, C. Comparison of 2D and 3D realistic models of white matter microstructure. University of Twente, 2019."},{"key":"10.1016\/j.arr.2024.102276_bib145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.arr.2024.102276_bib146","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib147","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","article-title":"Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia","volume":"49","author":"Lodi","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib148","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jval.2016.04.009","article-title":"Increasing patient involvement in drug development","volume":"19","author":"Lowe","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.arr.2024.102276_bib149","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein 2039 transmission initiates Parkinson-like neurodegeneration in 2040 nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102276_bib150","first-page":"S308","article-title":"The impact and management of nonmotor symptoms of Parkinson's disease","volume":"17","author":"Lyons","year":"2011","journal-title":"Am. J. Manag. Care"},{"issue":"1","key":"10.1016\/j.arr.2024.102276_bib151","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib152","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-010-0764-0","article-title":"Distinct pathological subtypes of FTLD-FUS","volume":"121","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib153","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.arr.2024.102276_bib154","doi-asserted-by":"crossref","DOI":"10.3171\/2015.8.FOCUS15328","article-title":"Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy","volume":"39","author":"Manix","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.arr.2024.102276_bib155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drudis.2007.10.019","article-title":"Strategies and tactics for optimizing the Hit-to-Lead process and beyond\u2014a computational chemistry perspective","volume":"13","author":"Manly","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102276_bib156","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2024.102276_bib157","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease","volume":"58","author":"McKhann","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib158","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1110\/ps.051997606","article-title":"M. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein","volume":"15","author":"Mclaughlin","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.arr.2024.102276_bib159","first-page":"1007","article-title":"Cortico-Basal Ganglia Interactions in Huntington\u2019s. Ann","volume":"1","author":"Mehrabi","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2024.102276_bib160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.91","article-title":"Primary progressive aphasia","volume":"49","author":"Mesulam","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib161","article-title":"Amyloidosis-history and development, emphasis on insulin and prion amyloids","author":"Metkar","year":"2023","journal-title":"Brain Disord."},{"key":"10.1016\/j.arr.2024.102276_bib162","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/bi301325q","article-title":"Membrane interactions of the amphipathic amino terminus of huntingtin","volume":"52","author":"Michalek","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102276_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005029.pub2","article-title":"Treatment for ataxia in multiple sclerosis","author":"Mills","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.arr.2024.102276_bib164","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer's disease\u2013do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00401-009-0598-9","article-title":"FUS pathology in basophilic inclusion body disease","volume":"118","author":"Munoz","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Nakashima-Yasuda","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib167","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10072-016-2632-8","article-title":"Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy","volume":"37","author":"Nasri","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib168","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-009-0581-5","article-title":"Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease","volume":"118","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib169","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ebcr.2014.01.004","article-title":"Treating seizures in Creutzfeldt\u2013Jakob disease","volume":"2","author":"Ng","year":"2014","journal-title":"Epilepsy Behav. case Rep."},{"key":"10.1016\/j.arr.2024.102276_bib170","doi-asserted-by":"crossref","first-page":"32344","DOI":"10.1074\/jbc.M109.035196","article-title":"Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation","volume":"284","author":"Niki","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib171","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1074\/jbc.M110.183780","article-title":"Development of defective and persistent Sendai virus vector a unique gene delivery\/expression system ideal for cell reprogramming","volume":"286","author":"Nishimura","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib172","unstructured":"NYK\u00c4NEN, N.-P. Cellular Physiology and Cell-to-Cell Propagation of Tau in Neurodegeneration: The Impact of Late-Onset Alzheimer\u2019s Disease Susceptibility Genes. 2016."},{"key":"10.1016\/j.arr.2024.102276_bib173","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/147342204100032331","article-title":"Pharmacological treatments of cerebellar ataxia","volume":"3","author":"Ogawa","year":"2004","journal-title":"Cerebellum"},{"key":"10.1016\/j.arr.2024.102276_bib174","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(03)00009-1","article-title":"D-cycloserine for the treatment of ataxia in spinocerebellar degeneration","volume":"210","author":"Ogawa","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1","volume":"4","author":"Orr","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib176","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","article-title":"A brief overview of tauopathy: causes, consequences, and therapeutic strategies","volume":"38","author":"Orr","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib177","first-page":"545","article-title":"Tetrabenazine in the treatment of Huntington\u2019s disease","volume":"3","author":"Paleacu","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.arr.2024.102276_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000112894","article-title":"Frontotemporal dementia: its rediscovery","volume":"38","author":"Pasquier","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib179","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molcel.2013.01.020","article-title":"The ribosome as a hub for protein quality control","volume":"49","author":"Pechmann","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.arr.2024.102276_bib180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-021-01101-x","article-title":"Neuroimaging in frontotemporal dementia: heterogeneity and relationships with underlying neuropathology","volume":"18","author":"Peet","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2024.102276_bib181","article-title":"One-year changes in brain microstructure differentiate preclinical Huntington's disease stages","volume":"25","author":"Pflanz","year":"2020","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.arr.2024.102276_bib182","doi-asserted-by":"crossref","unstructured":"Piazza, M., Prior, T.W., Khalsa, P.S., Appleby, B., 2020. A case report of genetic prion disease with two different PRNP variants. Molecular Genetics & Genomic. Medicine 8, e1134..","DOI":"10.1002\/mgg3.1134"},{"key":"10.1016\/j.arr.2024.102276_bib183","first-page":"165","article-title":"Uber die Beziehungen der senilen Hirnatrophie zur Aphasie","volume":"17","author":"Pick","year":"1892","journal-title":"Prag. Med Woche"},{"key":"10.1016\/j.arr.2024.102276_bib184","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2013\/705373","article-title":"The pathophysiology and pharmacological treatment of Huntington disease","volume":"26","author":"Pidgeon","year":"2013","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02328","article-title":"The development of serum amyloid P as a possible therapeutic","volume":"9","author":"Pilling","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102276_bib186","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1007\/s12035-016-0214-7","article-title":"Neurotrophin signaling and stem cells\u2014implications for neurodegenerative diseases and stem cell therapy","volume":"54","author":"Pramanik","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102276_bib187","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","article-title":"Sporadic human prion diseases: molecular insights and diagnosis","volume":"11","author":"Puoti","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib188","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102276_bib189","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbadis.2006.05.004","article-title":"Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis","volume":"1762","author":"Rakhit","year":"2006","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.arr.2024.102276_bib190","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-008-0059-y","article-title":"The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole","volume":"115","author":"Rammes","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2024.102276_bib191","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Van Swieten, J.C.; Seelaar, H.; Dopper, E.G.; Onyike, C.U. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102276_bib192","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41582-021-00565-x","article-title":"Changing demography and the challenge of dementia in India","volume":"17","author":"Ravindranath","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib193","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib194","first-page":"215","article-title":"The complex molecular biology of amyotrophic lateral sclerosis (ALS)","volume":"Volume 107","author":"Redler","year":"2012"},{"key":"10.1016\/j.arr.2024.102276_bib195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib196","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.expneurol.2009.07.029","article-title":"Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs","volume":"223","author":"Rocher","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib197","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102276_bib198","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/brain\/awg204","article-title":"Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study","volume":"126","author":"Rosso","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102276_bib199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuron.2015.11.033","article-title":"Impaired mTORC1-dependent expression of homer-3 influences SCA1 pathophysiology","volume":"89","author":"Ruegsegger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102276_bib200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fpubh.2018.00181","article-title":"Phenotypic heterogeneity in dementia: a challenge for epidemiology and biomarker studies","volume":"6","author":"Ryan","year":"2018","journal-title":"Front. Public Health"},{"key":"10.1016\/j.arr.2024.102276_bib201","unstructured":"Sadek, R.M.; Mohammed, S.A.; Abunbehan, A.R.K.; Ghattas, A.K.H.A.; Badawi, M.R.; Mortaja, M.N.; Abu-Nasser, B.S.; Abu-Naser, S.S. Parkinson\u2019s Disease Prediction Using Artificial Neural Network. 2019."},{"key":"10.1016\/j.arr.2024.102276_bib202","first-page":"22","article-title":"Computer aided drug design: the most fundamental goal is to predict whether a given molecule will bind to a target and if so how strongly","volume":"4","author":"Sahu","year":"2013","journal-title":"Comp. Eng. Intell. Syst."},{"key":"10.1016\/j.arr.2024.102276_bib203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mdc3.12057","article-title":"Treatment options in degenerative cerebellar ataxia: a systematic review","volume":"1","author":"Sarva","year":"2014","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.arr.2024.102276_bib204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-8993(97)00097-8","article-title":"Human choroid plexus is an uniquely involved area of the brain in amyloidosis: a histochemical, immunohistochemical and ultrastructural study","volume":"755","author":"Sasaki","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2024.102276_bib205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000008054","article-title":"The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture","volume":"41","author":"Satoh","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.arr.2024.102276_bib206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer\u2019s disease: role of axonal transport","volume":"7","author":"Schindowski","year":"2008","journal-title":"Genes, brain Behav."},{"key":"10.1016\/j.arr.2024.102276_bib207","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1176\/jnp.16.3.367","article-title":"Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome","volume":"16","author":"Schmahmann","year":"2004","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib208","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2174\/1568026615666150610143510","article-title":"Computer aided drug design studies in the discovery of secondary metabolites targeted against age-related neurodegenerative diseases","volume":"15","author":"Scotti","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib209","article-title":"Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer\u2019s drug donepezil with human transferrin: Implications of Alzheimer\u2019s drug","author":"Shamsi","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2024.102276_bib210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom10050789","article-title":"MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: Insights into Alzheimer\u2019s disease therapy","volume":"10","author":"Shamsi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102276_bib211","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom10050789","article-title":"MARK4 Inhibited by AChE inhibitors, donepezil and rivastigmine tartrate: insights into alzheimer\u2019s disease therapy","volume":"10","author":"Shamsi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102276_bib212","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/1533317513504615","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease in Chinese patients: a pilot study","volume":"28","author":"Shea","year":"2013","journal-title":"Am. J. Alzheimer'S. Dis. Other Dement. \u00ae"},{"key":"10.1016\/j.arr.2024.102276_bib213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-005-1079-4","article-title":"Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation","volume":"110","author":"Shi","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib214","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijbiomac.2016.11.110","article-title":"Attenuation of amyloid fibrillation in presence of Warfarin: a biophysical investigation","volume":"95","author":"Siddiqi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102276_bib215","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1021\/acsomega.2c00155","article-title":"Chronic wasting disease (CWD) in cervids and the consequences of a mutable protein conformation","volume":"7","author":"Silva","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.arr.2024.102276_bib216","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"\u0160imi\u0107","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2024.102276_bib217","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnp.12297","article-title":"Changing perspectives on frontotemporal dementia: A review","volume":"17","author":"Snowden","year":"2023","journal-title":"J. Neuropsychol."},{"key":"10.1016\/j.arr.2024.102276_bib218","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-011-0816-0","article-title":"The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene","volume":"122","author":"Snowden","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib219","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13040-016-0082-8","article-title":"Initiative, A.s.D.N. Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer\u2019s disease: a study of ADNI cohorts","volume":"9","author":"Song","year":"2016","journal-title":"BioData Min."},{"key":"10.1016\/j.arr.2024.102276_bib220","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2174\/0929867311320180002","article-title":"Protein-ligand docking in the new millennium\u2013a retrospective of 10 years in the field","volume":"20","author":"Sousa","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib221","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1073\/pnas.95.13.7737","article-title":"Mutation in the tau gene in familial multiple system tauopathy with presenile dementia","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib222","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2249.1993.tb05999.x","article-title":"On the association between amyloid fibrils and glycosaminoglycans; possible interactive role of Ca2+ and amyloid P-component","volume":"94","author":"Stenstad","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.arr.2024.102276_bib223","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102276_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: the key peptide in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102276_bib225","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1128\/JVI.75.7.3453-3461.2001","article-title":"Branched polyamines cure prion-infected neuroblastoma cells","volume":"75","author":"Supattapone","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.arr.2024.102276_bib226","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2024.102276_bib227","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/pmj.78.923.513","article-title":"Motor neurone disease","volume":"78","author":"Talbot","year":"2002","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.arr.2024.102276_bib228","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drudis.2010.01.004","article-title":"Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection","volume":"15","author":"Tan","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102276_bib229","first-page":"95","article-title":"Protein denaturation","volume":"24","author":"Tanford","year":"1970","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.arr.2024.102276_bib230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/cjn.2022.69","article-title":"Recent advances in frontotemporal dementia","volume":"50","author":"Tartaglia","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib231","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcimb.2015.00033","article-title":"New insight into the molecular control of bacterial functional amyloids","volume":"5","author":"Taylor","year":"2015","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.arr.2024.102276_bib232","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"Huntington disease: a quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib233","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.581374","article-title":"Molecular chaperones: a double-edged sword in neurodegenerative diseases","volume":"12","author":"Tittelmeier","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib234","unstructured":"Todd, P.K.; Shakkottai, V.G. Overview of cerebellar ataxia in adults. UpToDate Inc 2019."},{"key":"10.1016\/j.arr.2024.102276_bib235","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2024.102276_bib236","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of \u03b1-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102276_bib237","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2741\/4204","article-title":"The triple power of D (3): protein intrinsic disorder in degenerative diseases","volume":"19","author":"Uversky","year":"2014","journal-title":"Front Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.arr.2024.102276_bib238","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-biochem-061516-045049","article-title":"Propagation of protein aggregation in neurodegenerative diseases","volume":"88","author":"Vaquer-Alicea","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.arr.2024.102276_bib239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0063-2","article-title":"The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington\u2019s disease model","volume":"10","author":"Veldman","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102276_bib240","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/JAD-2010-101632","article-title":"Memantine in behavioral variant frontotemporal dementia: negative results","volume":"23","author":"Vercelletto","year":"2011","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102276_bib241","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12974-023-02850-6","article-title":"Alzheimer\u2019s disease-associated complement gene variants influence plasma complement protein levels","volume":"20","author":"Veteleanu","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102276_bib242","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1745017901309010088","article-title":"Epidemiology of early-onset dementia: a review of the literature","volume":"9","author":"Vieira","year":"2013","journal-title":"Clin. Pract. Epidemiol. Ment. Health.: CP EMH"},{"key":"10.1016\/j.arr.2024.102276_bib243","first-page":"1","article-title":"A\u03b2 plaques","author":"Walker","year":"2020","journal-title":"Free Neuropathol."},{"key":"10.1016\/j.arr.2024.102276_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112647","article-title":"Involvement of molecular chaperone in protein-misfolding brain diseases","volume":"147","author":"Wankhede","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2024.102276_bib245","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2174\/1389450121999201230204050","article-title":"An insight into mitochondrial dysfunction and its implications in neurological diseases","volume":"22","author":"Waseem","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.arr.2024.102276_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2019.06.008","article-title":"Nature and regulation of protein folding on the ribosome","author":"Waudby","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib247","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib248","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib249","doi-asserted-by":"crossref","first-page":"a033969","DOI":"10.1101\/cshperspect.a033969","article-title":"Modulation of amyloid states by molecular chaperones","volume":"11","author":"Wentink","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2024.102276_bib250","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41593-018-0113-5","article-title":"TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD","volume":"21","author":"White","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib251","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. rare Dis."},{"key":"10.1016\/j.arr.2024.102276_bib252","series-title":"Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease","first-page":"497","article-title":"Animal prion diseases","author":"Windl","year":"2012"},{"key":"10.1016\/j.arr.2024.102276_bib253","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","article-title":"Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease","volume":"85","author":"Wischik","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102276_bib254","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/brain\/aws360","article-title":"The cerebellum in Parkinson\u2019s disease","volume":"136","author":"Wu","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102276_bib255","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/hmg\/ddg156","article-title":"Huntingtin contains a highly conserved nuclear export signal","volume":"12","author":"Xia","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2024.102276_bib256","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.695808","article-title":"APP, PSEN1, and PSEN2 variants in Alzheimer\u2019s disease: Systematic Re-evaluation according to ACMG guidelines","volume":"13","author":"Xiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102276_bib257","first-page":"8","article-title":"Amyotrophic lateral sclerosis and its mimics\/variants: a comprehensive review","author":"Yedavalli","year":"2018","journal-title":"J. Clin. Imaging Sci."},{"key":"10.1016\/j.arr.2024.102276_bib258","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: new perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102276_bib259","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/1043-4682(95)90012-8","article-title":"Spinocerebellar ataxia type 1","author":"Zoghbi","year":"1995","journal-title":"Proc. Semin. Cell Biol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:55:10Z","timestamp":1718488510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":259,"alternative-id":["S1568163724000941"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102276","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102276"}}